Status:
SUSPENDED
TAVI and Gender Outcomes Aortic Stenosis Undergoing Transfemoral Transcatheter Aortic Valve Implantation.
Lead Sponsor:
Imperial College Healthcare NHS Trust
Conditions:
Aortic Stenosis
Gender
Eligibility:
All Genders
18+ years
Brief Summary
Severe aortic stenosis (AS) is the commonest form of valvular abnormality in the developed world and transcatheter aortic valve implantation (TAVI) is now widely practiced as in many cases is the pref...
Detailed Description
Severe aortic stenosis (AS) is the commonest form of valvular abnormality in the developed world and accounts for more than 40% of patients with native valvular disease with an approximately equal pre...
Eligibility Criteria
Inclusion
- All comers - retrospective registry
Exclusion
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
14086 Patients enrolled
Trial Details
Trial ID
NCT04915976
Start Date
January 1 2007
End Date
January 1 2025
Last Update
December 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.